IL Biotechnology & Medical Research

Evogene Ltd (EVGN)

Track

Evogene Ltd witnessed two significant purchase transactions by insider Leon Recanati during August 2026. These acquisitions totaled 692,100 USD, involving 1.26 million shares. This activity occurred ahead of the upcoming August 18 earnings report, amidst a period where the stock price has declined 10.8 percent over the last ninety days.
Ticker: EVGN Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
RECANATI LEON Non-Executive Director
Transaction date
Purchase
Price
365.61
Quantity 50,877 +31.6%
Value US$3,300,558
RECANATI LEON Non-Executive Director
Transaction date
Purchase
Price
350.78
Quantity 28,769 -38.3%
Value US$2,801,797
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-13 2026-08-11 B Purchase
RECANATI LEON
Non-Executive Director
50,877 +31.6%
365.61
US$3,300,558 		50,877 +31.6% 365.61 US$3,300,558
2026-08-05 2026-08-04 B Purchase
RECANATI LEON
Non-Executive Director
28,769 -38.3%
350.78
US$2,801,797 		28,769 -38.3% 350.78 US$2,801,797
Explore more

More insider trading research around Evogene Ltd

More insider trades in IL
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity